Bergmark Richard L
CIK 0001282546 Name as filed on the most recent filing
Filed as Bergmark Richard L (18)
296 transaction lines · from 18 filings · filed 2004-03-03 to 2014-07-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
296 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2014-07-28 |
Core Laboratories N V CLB |
P, Open-market purchase | 3,205 acquired | 147.33 | 472,196.50 | Form 4, filing 0001000229-14-000092 | |
| 2014-07-28 |
Core Laboratories N V CLB |
P, Open-market purchase | 2,795 acquired | 146.91 | 410,606.74 | Form 4, filing 0001000229-14-000092 | |
| 2014-07-28 |
Core Laboratories N V CLB |
P, Open-market purchase | 1,000 acquired | 148.35 | 148,354.00 | Form 4, filing 0001000229-14-000092 | |
| 2013-08-07 |
Core Laboratories N V CLB |
S, Open-market sale | 15,200 disposed | 149.58 | 2,273,608.40 | Form 4, filing 0001140361-13-030938 | |
| 2013-08-07 |
Core Laboratories N V CLB |
S, Open-market sale | 3,000 disposed | 150.11 | 450,319.50 | Form 4, filing 0001140361-13-030938 | |
| 2013-08-07 |
Core Laboratories N V CLB |
S, Open-market sale | 1,800 disposed | 148.75 | 267,747.48 | Form 4, filing 0001140361-13-030938 | |
| 2011-07-25 |
Core Laboratories N V CLB |
S, Open-market sale | 43,627 disposed | 111.72 | 4,874,056.43 | Form 4, filing 0001140361-11-038183 | |
| 2011-07-25 |
Core Laboratories N V CLB |
S, Open-market sale | 6,373 disposed | 112.04 | 714,007.98 | Form 4, filing 0001140361-11-038183 | |
| 2010-07-28 |
Core Laboratories N V CLB |
S, Open-market sale | 26,913 disposed | 76.44 | 2,057,297.00 | Form 4, filing 0001140361-10-030896 | |
| 2010-07-28 |
Core Laboratories N V CLB |
S, Open-market sale | 938 disposed | 75.98 | 71,266.52 | Form 4, filing 0001140361-10-030896 | |
| 2010-07-27 |
Core Laboratories N V CLB |
S, Open-market sale | 12,149 disposed | 77.72 | 944,166.82 | Form 4, filing 0001140361-10-030896 | |
| 2010-02-17 |
Core Laboratories N V CLB |
S, Open-market sale | 24,546 disposed | 123.36 | 3,028,075.56 | Form 4, filing 0001140361-10-007375 | |
| 2010-02-17 |
Core Laboratories N V CLB |
S, Open-market sale | 10,454 disposed | 122.91 | 1,284,898.00 | Form 4, filing 0001140361-10-007375 | |
| 2009-11-02 |
Core Laboratories N V CLB |
S, Open-market sale | 11,918 disposed | 104.57 | 1,246,253.34 | Form 4, filing 0001140361-09-024332 | |
| 2009-11-02 |
Core Laboratories N V CLB |
S, Open-market sale | 11,114 disposed | 105.40 | 1,171,404.49 | Form 4, filing 0001140361-09-024332 | |
| 2009-11-02 |
Core Laboratories N V CLB |
S, Open-market sale | 3,269 disposed | 106.03 | 346,601.94 | Form 4, filing 0001140361-09-024332 | |
| 2009-11-02 |
Core Laboratories N V CLB |
S, Open-market sale | 3,218 disposed | 103.76 | 333,887.77 | Form 4, filing 0001140361-09-024332 | |
| 2009-10-30 |
Core Laboratories N V CLB |
S, Open-market sale | 6,710 disposed | 105.37 | 707,006.53 | Form 4, filing 0001140361-09-024332 | |
| 2009-10-30 |
Core Laboratories N V CLB |
S, Open-market sale | 6,660 disposed | 104.58 | 696,504.80 | Form 4, filing 0001140361-09-024332 | |
| 2009-10-30 |
Core Laboratories N V CLB |
S, Open-market sale | 3,715 disposed | 106.20 | 394,514.80 | Form 4, filing 0001140361-09-024332 | |
| 2009-10-30 |
Core Laboratories N V CLB |
S, Open-market sale | 3,396 disposed | 103.58 | 351,761.08 | Form 4, filing 0001140361-09-024332 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 9,484 disposed | 126.75 | 1,202,097.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 4,350 disposed | 126.80 | 551,580.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 3,300 disposed | 126.90 | 418,770.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 1,100 disposed | 126.78 | 139,458.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 1,000 disposed | 126.83 | 126,830.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 1,000 disposed | 126.79 | 126,790.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 900 disposed | 126.82 | 114,138.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 700 disposed | 126.81 | 88,767.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 615 disposed | 126.85 | 78,012.75 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 600 disposed | 126.87 | 76,122.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 500 disposed | 126.74 | 63,370.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 450 disposed | 126.89 | 57,100.50 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 400 disposed | 126.86 | 50,744.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 400 disposed | 126.84 | 50,736.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 400 disposed | 126.73 | 50,692.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 331 disposed | 126.95 | 42,020.45 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 300 disposed | 127.00 | 38,100.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 200 disposed | 126.96 | 25,392.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 200 disposed | 126.92 | 25,384.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 200 disposed | 126.88 | 25,376.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 200 disposed | 126.76 | 25,352.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 100 disposed | 126.94 | 12,694.00 | Form 4, filing 0001209191-08-014107 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 22,499 disposed | 126.60 | 2,848,373.40 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 5,450 disposed | 126.40 | 688,880.00 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 4,460 disposed | 126.50 | 564,190.00 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 3,130 disposed | 126.65 | 396,414.50 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 1,336 disposed | 126.70 | 169,271.20 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 700 disposed | 126.64 | 88,648.00 | Form 4, filing 0001209191-08-014101 | |
| 2008-02-27 |
Core Laboratories N V CLB |
S, Open-market sale | 600 disposed | 126.69 | 76,014.00 | Form 4, filing 0001209191-08-014101 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 5
- Open-market sale 291
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. BERGMARK RICHARD L, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001282546
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6